On the Role of Asymptomatic Infection in Transmission Dynamics of Infectious Diseases

Abstract We propose a compartmental disease transmission model with an asymptomatic (or subclinical) infective class to study the role of asymptomatic infection in the transmission dynamics of infectious diseases with asymptomatic infectives, e.g., influenza. Analytical results are obtained using the respective ratios of susceptible, exposed (incubating), and asymptomatic classes to the clinical symptomatic infective class. Conditions are given for bistability of equilibria to occur, where trajectories with distinct initial values could result in either a major outbreak where the disease spreads to the whole population or a lesser outbreak where some members of the population remain uninfected. This dynamic behavior did not arise in a SARS model without asymptomatic infective class studied by Hsu and Hsieh (SIAM J. Appl. Math. 66(2), 627–647, 2006). Hence, this illustrates that depending on the initial states, control of a disease outbreak with asymptomatic infections may involve more than simply reducing the reproduction number. Moreover, the presence of asymptomatic infections could result in either a positive or negative impact on the outbreak, depending on different sets of conditions on the parameters, as illustrated with numerical simulations. Biological interpretations of the analytical and numerical results are also given.

[1]  C. Macken,et al.  Mitigation strategies for pandemic influenza in the United States. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Sze-Bi Hsu,et al.  Modeling Intervention Measures and Severity-Dependent Public Response during Severe Acute Respiratory Syndrome Outbreak , 2005, SIAM J. Appl. Math..

[3]  A. Nizam,et al.  Containing Pandemic Influenza at the Source , 2005, Science.

[4]  E. Schouten,et al.  A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection , 2003, Journal of Clinical Epidemiology.

[5]  Ying-Hen Hsieh,et al.  Impact of Travel Between Patches for Spatial Spread of Disease , 2007, Bulletin of mathematical biology.

[6]  A S Perelson,et al.  Emergence of drug resistance during an influenza epidemic: insights from a mathematical model. , 1998, The Journal of infectious diseases.

[7]  R. Couch,et al.  Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza. , 1981, Antiviral research.

[8]  A. Monto,et al.  Prevention of Russian influenza by amantadine. , 1979, JAMA.

[9]  D. Cummings,et al.  Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.

[10]  E. Birt,et al.  Administration of amantadine for the prevention of Hong Kong influenza. , 1970, Bulletin of the World Health Organization.

[11]  P. Chan,et al.  Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  F. Brauer,et al.  Simple models for containment of a pandemic , 2006, Journal of The Royal Society Interface.

[13]  Keiji Fukuda,et al.  Nonpharmaceutical Interventions for Pandemic Influenza, International Measures , 2006, Emerging infectious diseases.

[14]  F. V. Vleck,et al.  Stability and Asymptotic Behavior of Differential Equations , 1965 .

[15]  D. Cummings,et al.  Strategies for mitigating an influenza pandemic , 2006, Nature.

[16]  R. Webster Wet markets—a continuing source of severe acute respiratory syndrome and influenza? , 2004, The Lancet.

[17]  Ronald Eccles Asymptomatic spread of flu is not proved , 2005, BMJ : British Medical Journal.

[18]  R. Pettersson,et al.  Protection of Man from Natural Infection with Influenza A2 Hong Kong Virus by Amantadine: A Controlled Field Trial , 1970, British medical journal.

[19]  A. Nizam,et al.  Containing pandemic influenza with antiviral agents. , 2004, American journal of epidemiology.

[20]  R. Pettersson,et al.  Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients. , 1980, The Journal of infectious diseases.